Streetbeat News

Price Targets

UNCY

HC Wainwright & Co. analyst Ed Arce has reiterated a Buy rating on Unicycive Therapeutics (NASDAQ:UNCY) and maintained a price target of $4.5.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:27 am

CKPT

HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Checkpoint Therapeutics (NASDAQ:CKPT) and maintained a $34 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:24 am

CARA

HC Wainwright & Co. analyst Oren Livnat has maintained a Buy rating on Cara Therapeutics (NASDAQ:CARA) but has reduced the price target from $7 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:22 am

RICK

HC Wainwright & Co. analyst Scott Buck has reiterated a Buy rating on RCI Hospitality Holdings (NASDAQ:RICK) with a maintained price target of $115.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:20 am

PAYO

Needham analyst Mayank Tandon has reiterated a Buy rating on Payoneer Global (NASDAQ:PAYO) and maintained the $8 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:18 am

KRON

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on Kronos Bio (NASDAQ:KRON) but reduced the price target from $9 to $2.5.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:16 am

REE

HC Wainwright & Co. analyst Amit Dayal has initiated coverage on REE Automotive (NASDAQ:REE) with a Buy rating and set a price target of $15.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:14 am

IONS

Needham analyst Joseph Stringer has reiterated a Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) and maintained a $60 price target on the stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:10 am

KVYO

Needham analyst Scott Berg has reiterated a Buy rating on Klaviyo (NYSE:KVYO) and maintained a $40 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:09 am

KNTK

Citigroup analyst Spiro Dounis has reinstated a Neutral rating on Kinetik Holdings (NYSE:KNTK) and maintained a $35 price target on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:08 am